Literature DB >> 15254203

Role of CD8+ T cells in control of West Nile virus infection.

Bimmi Shrestha1, Michael S Diamond.   

Abstract

Infection with West Nile virus (WNV) causes fatal encephalitis more frequently in immunocompromised humans than in those with a healthy immune system. Although a complete understanding of this increased risk remains unclear, experiments with mice have begun to define how different components of the adaptive and innate immune response function to limit infection. Previously, we demonstrated that components of humoral immunity, particularly immunoglobulin M (IgM) and IgG, have critical roles in preventing dissemination of WNV infection to the central nervous system. In this study, we addressed the function of CD8(+) T cells in controlling WNV infection. Mice that lacked CD8(+) T cells or classical class Ia major histocompatibility complex (MHC) antigens had higher central nervous system viral burdens and increased mortality rates after infection with a low-passage-number WNV isolate. In contrast, an absence of CD8(+) T cells had no effect on the qualitative or quantitative antibody response and did not alter the kinetics or magnitude of viremia. In the subset of CD8(+)-T-cell-deficient mice that survived initial WNV challenge, infectious virus was recovered from central nervous system compartments for several weeks. Primary or memory CD8(+) T cells that were generated in vivo efficiently killed target cells that displayed WNV antigens in a class I MHC-restricted manner. Collectively, our experiments suggest that, while specific antibody is responsible for terminating viremia, CD8(+) T cells have an important function in clearing infection from tissues and preventing viral persistence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15254203      PMCID: PMC446114          DOI: 10.1128/JVI.78.15.8312-8321.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  70 in total

1.  West Nile poliomyelitis.

Authors:  A Arturo Leis; Jonathan Fratkin; Dobrivoje S Stokic; Theresa Harrington; Risa M Webb; Sally A Slavinski
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

2.  West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro.

Authors:  Y Liu; N King; A Kesson; R V Blanden; A Müllbacher
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

3.  Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.

Authors:  J Kimura-Kuroda; K Yasui
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

4.  Persistence of tick-borne encephalitis virus in monkeys. II. Effectiveness of methods used for virus detection.

Authors:  V V Pogodina; G V Malenko; G I Fokina; L S Levina; G V Koreshkova; O E Rzhakhova; N G Bochkova; L L Mamonenko
Journal:  Acta Virol       Date:  1981-11       Impact factor: 1.162

5.  A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.

Authors:  F X Heinz; R Berger; W Tuma; C Kunz
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

6.  Study on West Nile virus persistence in monkeys.

Authors:  V V Pogodina; M P Frolova; G V Malenko; G I Fokina; G V Koreshkova; L L Kiseleva; N G Bochkova; N M Ralph
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 7.  Antibody prophylaxis and therapy for flavivirus encephalitis infections.

Authors:  J T Roehrig; L A Staudinger; A R Hunt; J H Mathews; C D Blair
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

8.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses.

Authors:  Matthew McCown; Michael S Diamond; Andrew Pekosz
Journal:  Virology       Date:  2003-09-01       Impact factor: 3.616

10.  Partial genetic characterization of West Nile virus strains, New York State, 2000.

Authors:  G D Ebel; A P Dupuis; K Ngo; D Nicholas; E Kauffman; S A Jones; D Young; J Maffei; P Y Shi; K Bernard; L D Kramer
Journal:  Emerg Infect Dis       Date:  2001 Jul-Aug       Impact factor: 6.883

View more
  214 in total

1.  Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.

Authors:  Rekha Singh; Alan L Rothman; James Potts; Farshad Guirakhoo; Francis A Ennis; Sharone Green
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 3.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

4.  Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice.

Authors:  Annie Elong Ngono; Edward A Vizcarra; William W Tang; Nicholas Sheets; Yunichel Joo; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2017-01-11       Impact factor: 21.023

Review 5.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 6.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

7.  Construction and characterization of a single-cycle chimeric flavivirus vaccine candidate that protects mice against lethal challenge with dengue virus type 2.

Authors:  Ryosuke Suzuki; Evandro R Winkelmann; Peter W Mason
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

8.  Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis.

Authors:  Robyn S Klein; Eugene Lin; Bo Zhang; Andrew D Luster; Judy Tollett; Melanie A Samuel; Michael Engle; Michael S Diamond
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Authors:  Kristina S Burrack; Stephanie A Montgomery; Dirk Homann; Thomas E Morrison
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.